28 May 2026 Coronary bifurcation lesions side branch optimal treatment study: the BILBO multicentre study at EuroPCR 2026 Watch the full interview Previous Post:CTO PCI an evolving landscape Session comprising selected EuroPCR 2026 abstract submissions Next Post:the BILBO multicentre study on tctMD Category: Press